Nature Communications (Nov 2017)

Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis

  • Carole Henique,
  • Guillaume Bollée,
  • Xavier Loyer,
  • Florian Grahammer,
  • Neeraj Dhaun,
  • Marine Camus,
  • Julien Vernerey,
  • Léa Guyonnet,
  • François Gaillard,
  • Hélène Lazareth,
  • Charlotte Meyer,
  • Imane Bensaada,
  • Luc Legrès,
  • Takashi Satoh,
  • Shizuo Akira,
  • Patrick Bruneval,
  • Stefanie Dimmeler,
  • Alain Tedgui,
  • Alexandre Karras,
  • Eric Thervet,
  • Dominique Nochy,
  • Tobias B. Huber,
  • Laurent Mesnard,
  • Olivia Lenoir,
  • Pierre-Louis Tharaux

DOI
https://doi.org/10.1038/s41467-017-01885-7
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 15

Abstract

Read online

Crescentic rapidly progressive glomerulonephritis is a severe form of glomerula disease characterized by podocyte proliferation and migration. Here Henique et al. demonstrate that inhibition of miRNA-92a prevents kidney failure by promoting the expression of CDK inhibitor p57Kip2 that regulates podocyte cell cycle.